Risk factors for amyotrophic lateral sclerosis

References

• WijesekeraLCLeighPNAmyotrophic lateral sclerosisOrphanet J Rare Dis20094319192301
   PubMed Web of Science ®Google Scholar
• TalbotKMotor neuron disease: the bare essentialsPract Neurol20099530330919762894
   PubMedGoogle Scholar
• del AguilaMALongstrethWTJrMcGuireVKoepsellTDvan BelleGPrognosis in amyotrophic lateral sclerosis: a population-based studyNeurology200360581381912629239
   PubMed Web of Science ®Google Scholar
• ForsgrenLAlmayBGHolmgrenGWallSEpidemiology of motor neuron disease in northern SwedenActa Neurol Scand198368120296604389
   PubMed Web of Science ®Google Scholar
• Al-ChalabiALeighPNRecent advances in amyotrophic lateral sclerosisCurr Opin Neurol200013439740510970056
   PubMedGoogle Scholar
• DesaiJSwashMExtrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsionJ Neurol Neurosurg Psychiatry199967221421610406993
   PubMed Web of Science ®Google Scholar
• NearyDSnowdenJSGustafsonLFrontotemporal lobar degeneration: a consensus on clinical diagnostic criteriaNeurology1998516154615549855500
   PubMed Web of Science ®Google Scholar
• RentonAEMajounieEWaiteAA hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTDNeuron201172225726821944779
   PubMed Web of Science ®Google Scholar
• NeumannMSampathuDMKwongLKUbiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisScience2006314579613013317023659
   PubMed Web of Science ®Google Scholar
• Majoor-KrakauerDOttmanRJohnsonWGRowlandLPFamilial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson’s disease: evidence of shared genetic susceptibilityNeurology19944410187218777936240
   PubMed Web of Science ®Google Scholar
• HuismanMHde JongSWVerwijsMCFamily history of neurodegenerative and vascular diseases in ALS: a population-based studyNeurology201177141363136921940614
   PubMed Web of Science ®Google Scholar
• ByrneSHeverinMElaminMAggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosisAnn Neurol201374569970823836460
   PubMed Web of Science ®Google Scholar
• FallisBAHardimanOAggregation of neurodegenerative disease in ALS kindredsAmyotroph Lateral Scler2009102959818608094
   PubMed Web of Science ®Google Scholar
• ByrneSBedePElaminMProposed criteria for familial amyotrophic lateral sclerosisAmyotroph Lateral Scler201112315715921208036
   PubMed Web of Science ®Google Scholar
• McGuireVLongstrethWTJrKoepsellTDvan BelleGIncidence of amyotrophic lateral sclerosis in three counties in western Washington StateNeurology19964725715738757041
   PubMed Web of Science ®Google Scholar
• TraynorBJCoddMBCorrBFordeCFrostEHardimanOIncidence and prevalence of ALS in Ireland, 1995–1997: a population-based studyNeurology199952350450910025778
   PubMed Web of Science ®Google Scholar
• BeghiEMillulAMicheliAVitelliELogroscinoGIncidence of ALS in Lombardy, ItalyNeurology200768214114517210896
   PubMed Web of Science ®Google Scholar
• VazquezMCKetzoianCLegnaniCIncidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based studyNeuroepidemiology200830210511118334826
   PubMed Web of Science ®Google Scholar
• JohnstonCAStantonBRTurnerMRAmyotrophic lateral sclerosis in an urban setting: a population based study of inner city LondonJ Neurol2006253121642164317219036
   PubMed Web of Science ®Google Scholar
• TestaDLovatiRFerrariniMSalmoiraghiFFilippiniGSurvival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year periodAmyotroph Lateral Scler Other Motor Neuron Disord20045420821215799548
   PubMed Web of Science ®Google Scholar
• LogroscinoGTraynorBJHardimanOIncidence of amyotrophic lateral sclerosis in EuropeJ Neurol Neurosurg Psychiatry201081438539019710046
   PubMed Web of Science ®Google Scholar
• CudkowiczMEMcKenna-YasekDSappPEEpidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosisAnn Neurol19974122102219029070
   PubMed Web of Science ®Google Scholar
• JunejaTPericak-VanceMALaingNGDaveSSiddiqueTPrognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutaseNeurology199748155579008494
   PubMed Web of Science ®Google Scholar
• HuismanMHde JongSWvan DoormaalPTPopulation based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodologyJ Neurol Neurosurg Psychiatry201182101165117021622937
   PubMed Web of Science ®Google Scholar
• UenalHRosenbohmAKufeldtJIncidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany – completeness of the ALS registry SwabiaPLoS One201494e9393224722455
   PubMed Web of Science ®Google Scholar
• Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis (PARALS)Incidence of ALS in Italy: evidence for a uniform frequency in Western countriesNeurology200156223924411160962
   PubMed Web of Science ®Google Scholar
• FangFValdimarsdottirUBelloccoRAmyotrophic lateral sclerosis in Sweden, 1991–2005Arch Neurol200966451551919364937
   PubMed Web of Science ®Google Scholar
• ManjalyZRScottKMAbhinavKThe sex ratio in amyotrophic lateral sclerosis: a population based studyAmyotroph Lateral Scler201011543944220225930
   PubMed Web of Science ®Google Scholar
• LandtblomAMRiiseTBoikoASoderfeldtBDistribution of multiple sclerosis in Sweden based on mortality and disability compensation statisticsNeuroepidemiology200221416717912065879
   PubMed Web of Science ®Google Scholar
• NeilsonSGunnarssonLGRobinsonIRising mortality from motor neurone disease in Sweden 1961–1990: the relative role of increased population life expectancy and environmental factorsActa Neurol Scand19949031501597847054
   PubMed Web of Science ®Google Scholar
• MaasiltaPJokelainenMLoytonenMSabelCEGatrellACMortality from amyotrophic lateral sclerosis in Finland, 1986–1995Acta Neurol Scand2001104423223511589652
   PubMed Web of Science ®Google Scholar
• SeljesethYMVollsetSETysnesOBIncreasing mortality from amyotrophic lateral sclerosis in Norway?Neurology20005591262126611087765
   PubMed Web of Science ®Google Scholar
• NeilsonSRobinsonINymoenEHLongitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966–1989: evidence for a susceptible subpopulationJ Neurol Sci199412221481548021698
   PubMed Web of Science ®Google Scholar
• NeilsonSRobinsonIAlperovitchARising amyotrophic lateral sclerosis mortality in France 1968–1990: increased life expectancy and inter-disease competition as an explanationJ Neurol199424174484557931447
   PubMed Web of Science ®Google Scholar
• StallonesLKasarskisEJStipanowichCSniderGSecular trends in mortality rates from motor neuron disease in Kentucky 1964–1984Neuroepidemiology19898268782922100
   PubMed Web of Science ®Google Scholar
• RiggsJELongitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the US, 1977–1986: evidence for an inherently susceptible population subsetMech Ageing Dev19905532072202232913
   PubMed Web of Science ®Google Scholar
• MurphyMQuinnSYoungJParkinPTaylorBIncreasing incidence of ALS in Canterbury, New Zealand: a 22-year studyNeurology200871231889189519047561
   PubMed Web of Science ®Google Scholar
• GovoniVGranieriEFallicaECasettaIAmyotrophic lateral sclerosis, rural environment and agricultural work in the Local Health District of Ferrara, Italy, in the years 1964–1998J Neurol2005252111322132715995797
   PubMed Web of Science ®Google Scholar
• CimaVLogroscinoGD’AscenzoCEpidemiology of ALS in Padova district, Italy, from 1992 to 2005Eur J Neurol200916892092419473365
   PubMed Web of Science ®Google Scholar
• Veiga-CaboJAlmazan-IslaJSendra-GutierrezJMde Pedro-CuestaJDifferential features of motor neuron disease mortality in SpainInt J Epidemiol1997265102410329363524
   PubMed Web of Science ®Google Scholar
• MandrioliJFaglioniPMerelliESolaPThe epidemiology of ALS in Modena, ItalyNeurology200360468368912601112
   PubMed Web of Science ®Google Scholar
• KihiraTYoshidaSHironishiMMiwaHOkamatoKKondoTChanges in the incidence of amyotrophic lateral sclerosis in Wakayama, JapanAmyotroph Lateral Scler Other Motor Neuron Disord20056315516316183557
   PubMed Web of Science ®Google Scholar
• OkamotoKKobashiGWashioMDescriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995–2001J Epidemiol2005151202315678922
   PubMed Web of Science ®Google Scholar
• SejvarJJHolmanRCBreseeJSKochanekKDSchonbergerLBAmyotrophic lateral sclerosis mortality in the United States, 1979–2001Neuroepidemiology200525314415215990445
   PubMed Web of Science ®Google Scholar
• PlatoCCGarrutoRMGalaskoDAmyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 yearsAm J Epidemiol2003157214915712522022
   PubMed Web of Science ®Google Scholar
• KuzuharaSKokuboYSasakiRFamilial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii Peninsula of Japan: clinical and neuropathological study and tau analysisAnn Neurol200149450151111310628
   PubMed Web of Science ®Google Scholar
• BensimonGLacomblezLMeiningerVA controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study GroupN Engl J Med199433095855918302340
   PubMed Web of Science ®Google Scholar
• LacomblezLBensimonGLeighPNGuilletPMeiningerVDose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group IILancet19963479013142514318676624
   PubMed Web of Science ®Google Scholar
• ArmonCAn evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosisNeuroepidemiology200322421722812792141
   PubMed Web of Science ®Google Scholar
• CruzDCNelsonLMMcGuireVLongstrethWTJrPhysical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population-based case-control studyNeuroepidemiology199918210111010023133
   PubMed Web of Science ®Google Scholar
• KamelFUmbachDMMunsatTLShefnerJMSandlerDPAssociation of cigarette smoking with amyotrophic lateral sclerosisNeuroepidemiology199918419420210364720
   PubMed Web of Science ®Google Scholar
• FangFKamelFLichtensteinPFamilial aggregation of amyotrophic lateral sclerosisAnn Neurol2009661949919670447
   PubMed Web of Science ®Google Scholar
• Al-ChalabiAFangFHanbyMFAn estimate of amyotrophic lateral sclerosis heritability using twin dataJ Neurol Neurosurg Psychiatry201081121324132620861059
   PubMed Web of Science ®Google Scholar
• RentonAEChioATraynorBJState of play in amyotrophic lateral sclerosis geneticsNat Neurosci2014171172324369373
   PubMed Web of Science ®Google Scholar
• AndersenPMAl-ChalabiAClinical genetics of amyotrophic lateral sclerosis: what do we really know?Nat Rev Neurol201171160361521989245
   PubMed Web of Science ®Google Scholar
• Dejesus-HernandezMMackenzieIRBoeveBFExpanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALSNeuron201172224525621944778
   PubMed Web of Science ®Google Scholar
• RentonAEMajounieEWaiteAA hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTDNeuron201172225726821944779
   PubMed Web of Science ®Google Scholar
• GijselinckIVan LangenhoveTvan der ZeeJA C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyLancet Neurol2012111546522154785
   PubMed Web of Science ®Google Scholar
• MillecampsSBoilléeSLe BerIPhenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genesJ Med Genet201249425826322499346
   PubMed Web of Science ®Google Scholar
• GijselinckIVan LangenhoveTvan der ZeeJA C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyLancet Neurol2012111546522154785
   PubMed Web of Science ®Google Scholar
• IshiuraHTakahashiYMitsuiJC9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of JapanArch Neurol20126991154115822637429
   PubMedGoogle Scholar
• BelzilVVBauerPOPrudencioMReduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in bloodActa Neuropathol2013126689590524166615
   PubMed Web of Science ®Google Scholar
• AndersenPMNilssonPForsgrenLMarklundSLCuZn-superoxide dismutase, extracellular superoxide dismutase, and glutathione peroxidase in blood from individuals homozygous for Asp90Ala CuZu-superoxide dismutase mutationJ Neurochem19987027157209453566
   PubMed Web of Science ®Google Scholar
• FelbeckerACamuWValdmanisPNFour familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?J Neurol Neurosurg Psychiatry201081557257720460594
   PubMed Web of Science ®Google Scholar
• RobberechtWAguirreTVan den BoschLTilkinPCassimanJJMatthijsGD90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosisNeurology1996475133613398909456
   PubMed Web of Science ®Google Scholar
• AndersenPAmyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase geneCurr Neurol Neurosci Rep200661374616469270
   PubMed Web of Science ®Google Scholar
• GurneyMPuHChiuAMotor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutationScience19942645166177217758209258
   PubMed Web of Science ®Google Scholar
• ReaumeAGElliottJLHoffmanEKMotor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injuryNat Genet199613143478673102
   PubMed Web of Science ®Google Scholar
• JonssonPAGraffmoKSAndersenPMDisulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis modelsBrain2006129Pt 245146416330499
   PubMed Web of Science ®Google Scholar
• BruijnLIHouseweartMKKatoSAggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1Science19982815384185118549743498
   PubMed Web of Science ®Google Scholar
• ZetterstromPStewartHGBergemalmDSoluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS modelsProc Natl Acad Sci U S A200710435141571416217715066
   PubMed Web of Science ®Google Scholar
• MackenzieIRRademakersRNeumannMTDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementiaLancet Neurol2010910995100720864052
   PubMed Web of Science ®Google Scholar
• TanCFEguchiHTagawaATDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutationActa Neuropathol2007113553554217333220
   PubMed Web of Science ®Google Scholar
• SreedharanJBlairIPTripathiVBTDP-43 mutations in familial and sporadic amyotrophic lateral sclerosisScience200831958701668167218309045
   PubMed Web of Science ®Google Scholar
• KabashiEValdmanisPNDionPTARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosisNat Genet200840557257418372902
   PubMed Web of Science ®Google Scholar
• Van DeerlinVMLeverenzJBBekrisLMTARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysisLancet Neurol20087540941618396105
   PubMed Web of Science ®Google Scholar
• YokosekiAShigaATanCFTDP-43 mutation in familial amyotrophic lateral sclerosisAnn Neurol200863453854218438952
   PubMed Web of Science ®Google Scholar
• RutherfordNJZhangYJBakerMNovel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosisPLoS Genet200849e100019318802454
   PubMed Web of Science ®Google Scholar
• BurattiEDorkTZuccatoEPaganiFRomanoMBaralleFENuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skippingEMBO J20012071774178411285240
   PubMed Web of Science ®Google Scholar
• StrongMJThe evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)J Neurol Sci20102881–211219840884
   PubMed Web of Science ®Google Scholar
• Lagier-TourenneCPolymenidouMClevelandDWTDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegenerationHum Mol Genet201019R1R46R6420400460
   PubMed Web of Science ®Google Scholar
• AraiTMackenzieIRHasegawaMPhosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodiesActa Neuropathol2009117212513619139911
   PubMed Web of Science ®Google Scholar
• ArmonCSmoking may be considered an established risk factor for sporadic ALSNeurology200973201693169819917993
   PubMed Web of Science ®Google Scholar
• WeisskopfMGMcCulloughMLCalleEEThunMJCudkowiczMAscherioAProspective study of cigarette smoking and amyotrophic lateral sclerosisAm J Epidemiol20041601263315229114
   PubMed Web of Science ®Google Scholar
• GalloVBueno-De-MesquitaHBVermeulenRSmoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohortAnn Neurol200965437838519399866
   PubMed Web of Science ®Google Scholar
• FangFBelloccoRHernanMAYeWSmoking, snuff dipping and the risk of amyotrophic lateral sclerosis – a prospective cohort studyNeuroepidemiology200627421722117106211
   PubMed Web of Science ®Google Scholar
• MalekAMBarchowskyABowserREnvironmental and occupational risk factors for amyotrophic lateral sclerosis: a case-control studyNeurodegener Dis201414313824246552
   PubMed Web of Science ®Google Scholar
• YuYSuFCCallaghanBCGoutmanSABattermanSAFeldmanELEnvironmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in MichiganPLoS One201496e10118624979055
   PubMed Web of Science ®Google Scholar
• Factor-LitvakPAl-ChalabiAAscherioACurrent pathways for epidemiological research in amyotrophic lateral sclerosisAmyotroph Lateral Scler Frontotemporal Degener201314Suppl 1334323678878
   PubMed Web of Science ®Google Scholar
• AscherioAWeisskopfMGO’ReillyEJVitamin E intake and risk of amyotrophic lateral sclerosisAnn Neurol200557110411015529299
   PubMed Web of Science ®Google Scholar
• WangHO’ReillyEJWeisskopfMGVitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studiesAm J Epidemiol2011173659560221335424
   PubMed Web of Science ®Google Scholar
• VeldinkJHKalmijnSGroeneveldGJIntake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosisJ Neurol Neurosurg Psychiatry200778436737116648143
   PubMed Web of Science ®Google Scholar
• OkamotoKKihiraTKobashiGFruit and vegetable intake and risk of amyotrophic lateral sclerosis in JapanNeuroepidemiology200932425125619209004
   PubMed Web of Science ®Google Scholar
• Michal FreedmanDKunclRWWeinsteinSJMalilaNVirtamoJAlbanesDVitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosisAmyotroph Lateral Scler Frontotemporal Degener201314424625123286756
   PubMed Web of Science ®Google Scholar
• de BustosFJimenez-JimenezFJMolinaJACerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosisJ Neural Transm19981056–77037089826112
   PubMed Web of Science ®Google Scholar
• IwasakiYIkedaKKinoshitaMVitamin A and E levels are normal in amyotrophic lateral sclerosisJ Neurol Sci199513221931948543947
   PubMed Web of Science ®Google Scholar
• GrafMEckerDHorowskiRHigh dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind studyJ Neural Transm2005112564966015517433
   PubMed Web of Science ®Google Scholar
• OkamotoKKihiraTKondoTNutritional status and risk of amyotrophic lateral sclerosis in JapanAmyotroph Lateral Scler Frontotemporal Degener200785300304
   PubMed Web of Science ®Google Scholar
• FitzgeraldKCO’ReillyEJFalconeGJDietary omega-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosisJAMA Neurol20147191102111025023276
   PubMed Web of Science ®Google Scholar
• BeghiEPupilloEMessinaPCoffee and amyotrophic lateral sclerosis: a possible preventive roleAm J Epidemiol201117491002100821946385
   PubMed Web of Science ®Google Scholar
• MorozovaNWeisskopfMGMcCulloughMLDiet and amyotrophic lateral sclerosisEpidemiology200819232433718300717
   PubMed Web of Science ®Google Scholar
• de JongSWHuismanMHSutedjaNASmoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based studyAm J Epidemiol2012176323323922791740
   PubMed Web of Science ®Google Scholar
• NelsonLMMcGuireVLongstrethWTJrMatkinCPopulation-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumptionAm J Epidemiol2000151215616310645818
   PubMed Web of Science ®Google Scholar
• TurnerMRIncreased premorbid physical activity and amyotrophic lateral sclerosis: born to run rather than run to death, or a seductive myth?J Neurol Neurosurg Psychiatry201384994723447649
   PubMed Web of Science ®Google Scholar
• MattssonPLonnstedtINygrenIAskmarkHPhysical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early ageJ Neurol Neurosurg Psychiatry201283439039420852312
   PubMed Web of Science ®Google Scholar
• DesportJCPreuxPMTruongTCVallatJMSautereauDCouratierPNutritional status is a prognostic factor for survival in ALS patientsNeurology19995351059106310496266
   PubMed Web of Science ®Google Scholar
• ShimizuTNagaokaUNakayamaYReduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in JapanAmyotroph Lateral Scler201213436336622632442
   PubMed Web of Science ®Google Scholar
• JawaidAMurthySBWilsonAMA decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALSAmyotroph Lateral Scler201011654254820500116
   PubMed Web of Science ®Google Scholar
• GalloVWarkPAJenabMPrediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohortNeurology201380982983823390184
   PubMed Web of Science ®Google Scholar
• O’ReillyEJWangHWeisskopfMGPremorbid body mass index and risk of amyotrophic lateral sclerosisAmyotroph Lateral Scler Frontotemporal Degener201314320521123134505
   PubMed Web of Science ®Google Scholar
• ChioABenziGDossenaMMutaniRMoraGSeverely increased risk of amyotrophic lateral sclerosis among Italian professional football playersBrain2005128Pt 347247615634730
   PubMed Web of Science ®Google Scholar
• AbelELFootball increases the risk for Lou Gehrig’s disease, amyotrophic lateral sclerosisPercept Mot Skills20071043 Pt 21251125417879657
   PubMed Web of Science ®Google Scholar
• ChioACalvoADossenaMGhiglionePMutaniRMoraGALS in Italian professional soccer players: the risk is still present and could be soccer-specificAmyotroph Lateral Scler200910420520919267274
   PubMed Web of Science ®Google Scholar
• LehmanEJHeinMJBaronSLGersicCMNeurodegenerative causes of death among retired National Football League playersNeurology201279191970197422955124
   PubMed Web of Science ®Google Scholar
• FelmusMTPattenBMSwankeLAntecedent events in amyotrophic lateral sclerosisNeurology1976262167172946326
   PubMed Web of Science ®Google Scholar
• GranieriECarrerasMTolaRMotor neuron disease in the province of Ferrara, Italy, in 1964–1982Neurology19883810160416083419606
   PubMed Web of Science ®Google Scholar
• Roelofs-IversonRAMulderDWElvebackLRKurlandLTMolgaardCAALS and heavy metals: a pilot case-control studyNeurology19843433933956538286
   PubMed Web of Science ®Google Scholar
• GregoireNSerratriceGRisk factors in amyotrophic lateral sclerosis. Initial results apropos of 35 casesRev Neurol (Paris)199114711706713 French1775824
   PubMed Web of Science ®Google Scholar
• SavicaRParisiJEWoldLEJosephsKAAhlskogJEHigh school football and risk of neurodegeneration: a community-based studyMayo Clin Proc201287433534022469346
   PubMed Web of Science ®Google Scholar
• HuismanMHSeelenMde JongSWLifetime physical activity and the risk of amyotrophic lateral sclerosisJ Neurol Neurosurg Psychiatry201384997698123418211
   PubMed Web of Science ®Google Scholar
• Al-ChalabiALeighPNTrouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis?Brain2005128Pt 345145315713848
   PubMed Web of Science ®Google Scholar
• McKeeACGavettBESternRATDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathyJ Neuropathol Exp Neurol201069991892920720505
   PubMed Web of Science ®Google Scholar
• PupilloEMessinaPGiussaniGPhysical activity and ALS. A European population-based, case-control studyAnn Neurol201475570871624706338
   PubMed Web of Science ®Google Scholar
• RoosPMStudies on Metals in Motor Neuron DiseaseStockholm, SwedenInstitute of Environmental Medicine, Karolinska Institutet2013
   Google Scholar
• GunnarssonLGBodinLEpidemiologiskt påvisade samband mellan Amyotrofisk Lateral Skleros (ALS) och faktorer i arbetsmiljönGothenburg, SwedenOccupational and Environmental Medicine, University of GothenburgIn press
   Google Scholar
• SutedjaNAFischerKVeldinkJHWhat we truly know about occupation as a risk factor for ALS: a critical and systematic reviewAmyotroph Lateral Scler2009105–629530119922116
   PubMed Web of Science ®Google Scholar
• FangFQuinlanPYeWWorkplace exposures and the risk of amyotrophic lateral sclerosisEnviron Health Perspect200911791387139219750102
   PubMed Web of Science ®Google Scholar
• BeardJDKamelFMilitary service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survivalEpidemiol Rev10312014 Epub ahead of print
   Web of Science ®Google Scholar
• VergaraXKheifetsLGreenlandSOksuzyanSChoYSMezeiGOccupational exposure to extremely low-frequency magnetic fields and neurodegenerative disease: a meta-analysisJ Occup Environ Med201355213514623389409
   PubMed Web of Science ®Google Scholar
• KheifetsLBowmanJDCheckowayHFuture needs of occupational epidemiology of extremely low frequency electric and magnetic fields: review and recommendationsOccup Environ Med2009662728018805878
   PubMed Web of Science ®Google Scholar
• FeychtingMJonssonFPedersenNLAhlbomAOccupational magnetic field exposure and neurodegenerative diseaseEpidemiology200314441341912843764
   PubMed Web of Science ®Google Scholar
• VergaraXMezeiGKheifetsLCase-control study of occupational exposure to electric shocks and magnetic fields and mortality from amyotrophic lateral sclerosis in the US, 1991–1999J Expo Sci Environ Epidemiol6112014 Epub ahead of print
   Web of Science ®Google Scholar
• FischerHVergaraXYostMSilvaMLombardiDKheifetsLDeveloping data based, modeling and expert elicitation JEMsPresented at the BioEM2014 ConferenceCape Town, South AfricaJune 9–14, 2014
   Google Scholar
• HussASpoerriAEggerMKromhoutHVermeulenROccupational exposure to magnetic fields and electric shocks and risk of ALS – the Swiss National CohortAmyotroph Lateral Scler Frontotemporal Degener9172014 Epub ahead of print
   Web of Science ®Google Scholar
• ZhouHChenGChenCYuYXuZAssociation between extremely low-frequency electromagnetic fields occupations and amyotrophic lateral sclerosis: a meta-analysisPLoS One2012711e4835423189129
   PubMed Web of Science ®Google Scholar
• HussASpoerriAEggerMRöösliMSwiss National Cohort StudyResidence near power lines and mortality from neurodegenerative diseases: longitudinal study of the Swiss populationAm J Epidemiol2009169216717518990717
   PubMed Web of Science ®Google Scholar
• MarcilioIGouveiaNPereira FilhoMLKheifetsLAdult mortality from leukemia, brain cancer, amyotrophic lateral sclerosis and magnetic fields from power lines: a case-control study in BrazilBraz J Epidemiol2011144580588
   Google Scholar
• KamelFUmbachDMHuHLead exposure as a risk factor for amyotrophic lateral sclerosisNeurodegener Dis200523–419520116909025
   PubMed Web of Science ®Google Scholar
• DeapenDMHendersonBEA case-control study of amyotrophic lateral sclerosisAm J Epidemiol198612357907993962963
   PubMed Web of Science ®Google Scholar
• McGuireVLongstrethWTJrNelsonLMOccupational exposures and amyotrophic lateral sclerosis. A population-based case-control studyAm J Epidemiol199714512107610889199537
   PubMed Web of Science ®Google Scholar
• GunnarssonLGBodinLSoderfeldtBAxelsonOA case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solventsBr J Ind Med199249117917981463680
   PubMedGoogle Scholar
• CampbellAMWilliamsERBarltropDMotor neurone disease and exposure to leadJ Neurol Neurosurg Psychiatry19703368778855497881
   PubMed Web of Science ®Google Scholar
• Pierce-RuhlandRPattenBMRepeat study of antecedent events in motor neuron diseaseAnn Clin Res19811321021077235610
   PubMedGoogle Scholar
• GreshamLSMolgaardCAGolbeckALSmithRAmyotrophic lateral sclerosis and occupational heavy metal exposure: a case-control studyNeuroepidemiology19865129383748267
   PubMedGoogle Scholar
• ArmonCKurlandLTDaubeJRO’BrienPCEpidemiologic correlates of sporadic amyotrophic lateral sclerosisNeurology1991417107710842067636
   PubMed Web of Science ®Google Scholar
• ChancellorAMSlatteryJMFraserHWarlowCPRisk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease RegisterJ Neurol Neurosurg Psychiatry19935611120012068229031
   PubMed Web of Science ®Google Scholar
• KamelFUmbachDMLehmanTAAmyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genesEnviron Health Perspect2003111101335133912896855
   PubMed Web of Science ®Google Scholar
• KamelFUmbachDMMunsatTLShefnerJMHuHSandlerDPLead exposure and amyotrophic lateral sclerosisEpidemiology200213331131911964933
   PubMed Web of Science ®Google Scholar
• AlbersKNelsonLTannerCLead exposure and amyotrophic lateral sclerosis in a Northern California populationNeuroepidemiology20093374
   Google Scholar
• HuHPaytonMKorrickSDeterminants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging studyAm J Epidemiol199614487497598857824
   PubMed Web of Science ®Google Scholar
• FangFKweeLCAllenKDAssociation between blood lead and the risk of amyotrophic lateral sclerosisAm J Epidemiol2010171101126113320406759
   PubMed Web of Science ®Google Scholar
• DobsonAWEriksonKMAschnerMManganese neurotoxicityAnn N Y Acad Sci2004101211512815105259
   PubMed Web of Science ®Google Scholar
• SjögrenBIregrenAFrechWEffects on the nervous system among welders exposed to aluminium and manganeseOccup Environ Med199653132408563855
   PubMed Web of Science ®Google Scholar
• EllingsenDGKonstantinovRBast-PettersenRA neurobehavioral study of current and former welders exposed to manganeseNeurotoxicology2008291485917942157
   PubMed Web of Science ®Google Scholar
• RoosPMLierhagenSFlatenTPSyversenTVesterbergONordbergMManganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosisExp Biol Med (Maywood)2012237780381022859739
   PubMed Web of Science ®Google Scholar
• DusekPRoosPMLitwinTSchneiderSAFlatenTPAasethJThe neurotoxicity of iron, copper and manganese in Parkinson’s and Wilson’s diseasesJ Trace Elem Med Biol622014 Epub ahead of print
   Web of Science ®Google Scholar
• KasarskisEJTandonLLovellMAEhmannWDAluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary studyJ Neurol Sci199513022032088586987
   PubMed Web of Science ®Google Scholar
• KwanJYJeongSYVan GelderenPIron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 Tesla MRI and pathologyPLoS One201274e3524122529995
   PubMed Web of Science ®Google Scholar
• KilnessAWHichbergFHAmyotrophic lateral sclerosis in a high selenium environmentJ Am Med Assoc19772372628432844
   Web of Science ®Google Scholar
• VincetiMBonviciniFRothmanKJVescoviLWangFThe relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control studyEnviron Health201097721134276
   PubMed Web of Science ®Google Scholar
• VincetiMSolovyevNMandrioliJCerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated seleniteNeurotoxicology201338253223732511
   PubMed Web of Science ®Google Scholar
• RoosPMVesterbergOSyversenTFlatenTPNordbergMMetal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosisBiol Trace Elem Res2013151215917023225075
   PubMed Web of Science ®Google Scholar
• SavettieriGSalemiGArcaraACassataMCastiglioneMGFierroBA case-control study of amyotrophic lateral sclerosisNeuroepidemiology1991105–62422451798425
   PubMed Web of Science ®Google Scholar
• MorahanJMPamphlettRAmyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case-control studyNeuroepidemiology200627313013516946624
   PubMed Web of Science ®Google Scholar
• WeisskopfMGMorozovaNO’ReillyEJProspective study of chemical exposures and amyotrophic lateral sclerosisJ Neurol Neurosurg Psychiatry200980555856119372290
   PubMed Web of Science ®Google Scholar
• BonviciniFMarcelloNMandrioliJPietriniVVincetiMExposure to pesticides and risk of amyotrophic lateral sclerosis: a population-based case-control studyAnn Ist Super Sanita201046328428720847462
   PubMed Web of Science ®Google Scholar
• DasKNagCGhoshMFamilial, environmental, and occupational risk factors in development of amyotrophic lateral sclerosisN Am J Med Sci20124835035522912943
   PubMedGoogle Scholar
• KamelFUmbachDMBedlackRSPesticide exposure and amyotrophic lateral sclerosisNeurotoxicology201233345746222521219
   PubMed Web of Science ®Google Scholar
• MalekAMBarchowskyABowserRYoukATalbottEOPesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALSEnviron Res201211711211922819005
   PubMed Web of Science ®Google Scholar
• CoxPABanackSAMurchSJDiverse taxa of cyanobacteria produce beta-N-methylamino-L-alanine, a neurotoxic amino acidProc Natl Acad Sci U S A2005102145074507815809446
   PubMed Web of Science ®Google Scholar
• PabloJBanackSACoxPACyanobacterial neurotoxin BMAA in ALS and Alzheimer’s diseaseActa Neurol Scand2009120421622519254284
   PubMed Web of Science ®Google Scholar
• JonassonSErikssonJBerntzonLTransfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposureProc Natl Acad Sci U S A2010107209252925720439734
   PubMed Web of Science ®Google Scholar
• AraozRMolgoJTandeau de MarsacNNeurotoxic cyanobacterial toxinsToxicon201056581382819660486
   PubMed Web of Science ®Google Scholar
• OkumuraHKurlandLTWaringSCAmyotrophic lateral sclerosis and polio: is there an association?Ann N Y Acad Sci19957532452567611634
   PubMed Web of Science ®Google Scholar
• BergerMMKoppNVitalCRedlBAymardMLinaBDetection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALSNeurology2000541202510636120
   PubMed Web of Science ®Google Scholar
• CermelliCVincetiMBerettiFRisk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7Eur J Epidemiol200318212312712733833
   PubMed Web of Science ®Google Scholar
• RowlandLPTen central themes in a decade of ALS researchAdv Neurol1991563231853764
   PubMedGoogle Scholar
• GardnerMBRetroviral leukemia and lower motor neuron disease in wild mice: natural history, pathogenesis, and genetic resistanceAdv Neurol1991564734791649545
   PubMedGoogle Scholar
• SteeleAJAl-ChalabiAFerranteKCudkowiczMEBrownRHJrGarsonJADetection of serum reverse transcriptase activity in patients with ALS and unaffected blood relativesNeurology200564345445815699374
   PubMed Web of Science ®Google Scholar
• HadlockKGMillerRGJinXElevated rates of antibody reactivity to HML-2/HERV-K but not other endogenous retroviruses in ALSAmyotroph Lateral Scler20045Suppl 263
   Google Scholar
• OluwoleSOYaoYConradiSKristenssonKKarlssonHElevated levels of transcripts encoding a human retroviral envelope protein (syncytin) in muscles from patients with motor neuron diseaseAmyotroph Lateral Scler200782677217453631
   PubMed Web of Science ®Google Scholar
• DouvilleRLiuJRothsteinJNathAIdentification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosisAnn Neurol201169114115121280084
   PubMed Web of Science ®Google Scholar
• AlfahadTNathARetroviruses and amyotrophic lateral sclerosisAntivir Res201399218018723707220
   PubMed Web of Science ®Google Scholar
• ChenHRichardMSandlerDPUmbachDMKamelFHead injury and amyotrophic lateral sclerosisAm J Epidemiol2007166781081617641152
   PubMed Web of Science ®Google Scholar
• PupilloEMessinaPLogroscinoGTrauma and amyotrophic lateral sclerosis: a case-control study from a population-based registryEur J Neurol201219121509151722537412
   PubMed Web of Science ®Google Scholar
• PetersTLFangFWeibullCESandlerDPKamelFYeWSevere head injury and amyotrophic lateral sclerosisAmyotroph Lateral Scler Frontotemporal Degener201314426727223286749
   PubMed Web of Science ®Google Scholar
• DesportJCPreuxPMMagyLFactors correlated with hypermetabolism in patients with amyotrophic lateral sclerosisAm J Clin Nutr200174332833411522556
   PubMed Web of Science ®Google Scholar
• LekoubouAMatshaTESobngwiEKengneAPEffects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic reviewBMC Res Notes2014717124661645
   PubMedGoogle Scholar
• TurnerMRGoldacreRRamagopalanSTalbotKGoldacreMJAutoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic studyNeurology201381141222122523946298
   PubMed Web of Science ®Google Scholar
• MariosaDKamelFBelloccoRYeWFangFAssociation between diabetes and amyotrophic lateral sclerosis in SwedenEur J Neurol
   Web of Science ®Google Scholar
• ZhengZShengLShangHStatins and amyotrophic lateral sclerosis: a systematic review and meta-analysisAmyotroph Lateral Scler Frontotemporal Degener201314424124523134508
   PubMed Web of Science ®Google Scholar
• DupuisLDenglerRHenekaMTA randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosisPLoS One201276e3788522715372
   PubMed Web of Science ®Google Scholar
• Plun-FavreauHLewisPAHardyJMartinsLMWoodNWCancer and neurodegeneration: between the devil and the deep blue seaPLoS Genet2010612e100125721203498
   PubMed Web of Science ®Google Scholar
• Tabares-SeisdedosRRubensteinJLInverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disordersNat Rev Neurosci201314429330423511909
   PubMed Web of Science ®Google Scholar
• BrainLCroftPBWilkinsonMMotor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease)Brain19658834795004284065
   PubMed Web of Science ®Google Scholar
• MitchellDMOlczakSARemission of a syndrome indistinguishable from motor neurone disease after resection of bronchial carcinomaBMJ197926183176177466340
   PubMed Web of Science ®Google Scholar
• SadotECarluerLCorciaPDelozierYLevyCViaderFBreast cancer and motor neuron disease: clinical study of seven casesAmyotroph Lateral Scler20078528829117852015
   PubMed Web of Science ®Google Scholar
• ChioABrignolioFMeineriPRossoMGTriboloASchifferDMotor neuron disease and malignancies: results of a population-based studyJ Neurol198823563743753171620
   PubMed Web of Science ®Google Scholar
• FreedmanDMTravisLBGridleyGKunclRWAmyotrophic lateral sclerosis mortality in 1.9 million US cancer survivorsNeuroepidemiology200525417618016103728
   PubMed Web of Science ®Google Scholar
• FoisAFWottonCJYeatesDTurnerMRGoldacreMJCancer in patients with motor neuron disease, multiple sclerosis and Parkinson’s disease: record linkage studiesJ Neurol Neurosurg Psychiatry201081221522119726405
   PubMed Web of Science ®Google Scholar
• FreedmanDMCurtisREDaughertySEGoedertJJKunclRWTuckerMAThe association between cancer and amyotrophic lateral sclerosisCancer Causes Control2013241556023090035
   PubMed Web of Science ®Google Scholar
• BaadePDFritschiLFreedmanDMMortality due to amyotrophic lateral sclerosis and Parkinson’s disease among melanoma patientsNeuroepidemiology2007281162017164565
   PubMed Web of Science ®Google Scholar
• SeelenMvan DoormaalPTVisserAEPrior medical conditions and the risk of amyotrophic lateral sclerosisJ Neurol2014261101949195625059395
   PubMed Web of Science ®Google Scholar
• FangFAl-ChalabiARonneviLOAmyotrophic lateral sclerosis and cancer: a register-based study in SwedenAmyotroph Lateral Scler Frontotemporal Degener2013145–636236823527497
   PubMed Web of Science ®Google Scholar
• FreedmanDMWuJDaughertySEKunclRWEnewoldLRPfeifferRMThe risk of amyotrophic lateral sclerosis after cancer in US elderly adults: a population-based prospective studyInt J Cancer201413571745175024550098
   PubMed Web of Science ®Google Scholar
• SreedharanJBrownRHJrAmyotrophic lateral sclerosis: problems and prospectsAnn Neurol201374330931624038380
   PubMed Web of Science ®Google Scholar
• EisenAAmyotrophic lateral sclerosis: a 40-year personal perspectiveJ Clin Neurosci200916450551219231200
   PubMed Web of Science ®Google Scholar
• IsmailACooper-KnockJHighleyJRConcurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72J Neurol Neurosurg Psychiatry2013841798723085936
   PubMed Web of Science ®Google Scholar
• XiZYunusovaYvan BlitterswijkMIdentical twins with the C9orf72 repeat expansion are discordant for ALSNeurology201483161476147825209579
   PubMed Web of Science ®Google Scholar
• MahleyRWHuangYApolipoprotein E sets the stage: response to injury triggers neuropathologyNeuron201276587188523217737
   PubMed Web of Science ®Google Scholar
• KakalachevaKLunemannJDEnvironmental triggers of multiple sclerosisFEBS Lett2011585233724372921486562
   PubMed Web of Science ®Google Scholar
• GoldmanSMKamelFRossGWHead injury, alpha-synuclein Rep1, and Parkinson’s diseaseAnn Neurol2012711404822275250
   PubMed Web of Science ®Google Scholar
• Al-ChalabiAHardimanOThe epidemiology of ALS: a conspiracy of genes, environment and timeNat Rev Neurol201391161762824126629
   PubMed Web of Science ®Google Scholar
• SwinnenBRobberechtWThe phenotypic variability of amyotrophic lateral sclerosisNat Rev Neurol2014101166167025311585
   PubMed Web of Science ®Google Scholar
• ZhengWAschnerMGhersi-EgeaJFBrain barrier systems: a new frontier in metal neurotoxicological researchToxicol Appl Pharmacol2003192111114554098
   PubMed Web of Science ®Google Scholar